Recent Placing History5 May 2023 22:15
RNS 7.2.19
£20m at 25p
'The Company anticipates significant growth opportunities for its flagship medical imaging products and D3S in the nuclear detection division. This has been evidenced by the new medical imaging contract announced on 28 January 2019. The contract is with an existing OEM customer and is expected to be worth a minimum of $58 million over a seven-year period. The Directors believe that the medical imaging and nuclear detection markets are each worth in excess of $100 million per annum.'
RNS 12.2.21
£13m at 15p
'While the Directors believe that current cash levels could see the business trade successfully into FY22, they consider that there is limited capacity to exploit new opportunities and that the proceeds from the Transaction will help the business scale up and accelerate new commercial opportunities across all markets, as outlined below, as well as providing strength to the balance sheet.'
RNS 5.5.23
£8m at 5p
'While the Directors believe that current cash levels, supported by cash flow forecasts, could see the business trade successfully through FY24, they consider that there is limited capacity to capture short-term growth opportunities and that the proceeds from the Transaction will help the business accelerate revenue growth and win market share, as outlined below. The proceeds of the Transaction would also strengthen the balance sheet to facilitate the Group's restructuring of its bank debt.'
KMK are clearly having a drink in the last chance saloon. Do consider this before taking up the open offer as it could easily end in tears.